Table 2. Correlation between different response and the PFS in patients treated with target therapy and chemotherapy (n = 29).
| Items | PFS (months) (95% CI) | Univariate analysis P* | Median survival (months) (95% CI) | Univariate analysis P* |
|---|---|---|---|---|
| 1. PR | 13.1(0.0–27.3) | 0.111 | - | 0.440 |
| SD | 6.9(1.2–12.5) | 24.1(0.0–48.8) | ||
| 2. PR + SD | 12.9(4.4–21.4) | <0.001 | - | <0.001 |
| PD | 1.5(0.9–2.2) | 5.7(0.0–11.8) | ||
| 3. SD | 6.9(1.2–12.5) | 0.002 | 24.1(0.0–48.8) | 0.028 |
| PD | 1.5(0.9–2.2) | 5.7(0.0–11.8) | ||
| 4. PR | 13.1(0.0–27.3) | <0.001 | - | <0.001 |
| PD | 1.5(0.9–2.2) | 5.7(0.0–11.8) |
Note:*Log-Rank test.
Abbreviations: CI, Confidence interval; OS, overall survival; PFS, progression free survival; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.